Get the Stockscreener App
24.39
2.74%
0.65
Sionna Therapeutics Inc stock is traded at $24.39, with a volume of 184.62K.
It is up +2.74% in the last 24 hours and up +28.23% over the past month.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
See More
Previous Close:
$23.74
Open:
$23.86
24h Volume:
184.62K
Relative Volume:
1.02
Market Cap:
$1.08B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+17.15%
1M Performance:
+28.23%
6M Performance:
+23.43%
1Y Performance:
+0.00%
1-Day Range:
$23.35
$25.00
1-Week Range:
$20.50
$25.00
52-Week Range:
$7.255
$25.00
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics Inc
Sector
Industry
Phone
617-819-2020
Address
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
24.39 | 944.15M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | Guggenheim | Buy |
| Mar-04-25 | Initiated | Stifel | Buy |
| Mar-04-25 | Initiated | TD Cowen | Buy |
Sionna Therapeutics Inc Stock (SION) Latest News
Will Sionna Therapeutics Inc. price bounce be sustainable2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
When is the best time to exit Sionna Therapeutics Inc.Earnings Recap Summary & High Conviction Buy Zone Alerts - Newser
Using data filters to optimize entry into Sionna Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
Trend analysis for Sionna Therapeutics Inc. this week2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
Full technical analysis of Sionna Therapeutics Inc. stock2025 Trading Recap & Low Risk High Reward Ideas - Newser
Why Sionna Therapeutics Inc. stock attracts strong analyst attentionWeekly Stock Recap & High Accuracy Trade Alerts - Newser
Will earnings trigger a reversal in Sionna Therapeutics Inc.July 2025 Decliners & Low Drawdown Investment Strategies - Newser
Real time social sentiment graph for Sionna Therapeutics Inc.July 2025 Patterns & Verified Technical Signals - Newser
Why Sionna Therapeutics Inc. is moving todayJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Can Sionna Therapeutics Inc. recover in the next quarter2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
How to track smart money flows in Sionna Therapeutics Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
What institutional flow reveals about Sionna Therapeutics Inc.2025 Key Lessons & Reliable Breakout Forecasts - Newser
Why AIFF stock attracts strong analyst attentionJuly 2025 Big Picture & Safe Entry Momentum Tips - Newser
Drawdown in Sionna Therapeutics Inc. May Be Nearing End2025 Trading Recap & Fast Entry High Yield Stock Tips - beatles.ru
How hedge fund analytics apply to Sionna Therapeutics Inc. stockGold Moves & Real-Time Chart Breakout Alerts - Newser
How institutional ownership impacts Sionna Therapeutics Inc. stockJuly 2025 Pullbacks & Weekly High Return Opportunities - Newser
Bollinger Bands Show Potential Breakout in Sionna Therapeutics Inc.Weekly Gains Summary & Fast Entry Momentum Alerts - sundaytimes.kr
How to use a screener to detect Sionna Therapeutics Inc. breakouts2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Custom strategy builders for tracking Sionna Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Top chart patterns to watch in Sionna Therapeutics Inc.July 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Quantitative breakdown of Sionna Therapeutics Inc. recent move2025 Earnings Impact & Verified Swing Trading Watchlists - Newser
Sentiment analysis tools applied to Sionna Therapeutics Inc.July 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser
Sionna Therapeutics (NASDAQ:SION) Upgraded to “Hold” at Wall Street Zen - Defense World
Has Sionna Therapeutics Inc. found a price floor2025 Winners & Losers & High Accuracy Investment Entry Signals - Newser
Biopharma IPO drought continues: chance of rain expected? - BioWorld MedTech
What earnings revisions data tells us about Sionna Therapeutics Inc.Weekly Profit Report & Long-Term Growth Portfolio Plans - Newser
Sionna Therapeutics Inc Stock (SION) Financials Data
There is no financial data for Sionna Therapeutics Inc (SION). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Sionna Therapeutics Inc Stock (SION) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cloonan Michael | President & CEO |
Aug 20 '25 |
Sale |
22.75 |
25,000 |
568,750 |
547,343 |
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 19 '25 |
Sale |
21.08 |
34,500 |
727,260 |
89,032 |
| Ridloff Elena | CFO & Head of Corp. Dev. |
Aug 20 '25 |
Sale |
22.69 |
17,500 |
397,075 |
71,532 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):